Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Ugur Sahin

BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM

BioNTech (NASDAQ:BNTX) used its virtual annual general meeting to outline a transition year marked by leadership changes, continued investment in oncology, a planned share repurchase program and a restructuring of its manufacturing network. Chairman of the Supervisory Board Helmut Jeggle said the 2

MarketBeat

Plan for mRNA cancer vaccine trials to start in United Kingdom this year

Personalised cancer vaccine trials in England will roll out this year after the United Kingdom government signed a deal with a company behind one of the major COVID-19 vaccines.

ABC News

UK signs groundbreaking mRNA cancer vaccine research agreement

The partnership with German pharmaceutical company BioNTech will be one of the first of its kind

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

UK Health Secretary to sign cancer treatments deal for patients in England

Steve Barclay is set to sign a memorandum of understanding with BioNTech to ensure high quality cancer treatments are available as soon as possible

Wales Online

Health Secretary to sign cancer treatments deal with leading pharmaceutical company

Steve Barclay is due to sign a memorandum of understanding with BioNTech on Friday.

The Independent UK

'Cancer vaccine' could be available in next 10 years as scientists behind vital jab raise hopes

German couple Professors Ugur Sahin and Ozlem Tureci said they are hesitant to say they can find a cure for cancer, but that they have had “breakthroughs” they will keep working on.

Irish Mirror

Covid vaccine lessons could 'accelerate cancer vaccine' in next 8 years

The founders of coronavirus jab manufacturers BioNTech say developing it gave back to their cancer work

Wales Online

Read news from The Economist, FT, and more,
with one subscription

Cancer vaccines will be available within 10 years thanks to Covid jabs, scientists say

Ugur Sahin and Ozlem Tureci, the founders of leading coronavirus vaccine makers BioNTech, have had significant “breakthroughs” in cancer research

Daily Mirror

Cancer vaccine could be ready by 2030, scientists behind Covid jab say

‘We have a number of breakthroughs and we will continue to work on them’

The Independent UK

Cancer vaccine could be available by 2030, say scientists behind Covid jab

German couple Professors Ugur Sahin and Ozlem Tureci said they have had ‘breakthroughs’ they will keep working on.

The Independent UK

mRNA Vaccine Maker CEOs Pocketed $100M In Pandemic Pay: FT

The CEOs of Pfizer Inc (NYSE: PFE), BioNTech SE (NASDAQ: BNTX), and Moderna Inc (NASDAQ: MRNA) have sha

Benzinga

Will AI turbocharge the hunt for new drugs?

Advocates point to the pandemic as proof of its value in healthcare even as critics dismiss its use in drug discovery as ‘hype’

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.